Formulation development and risk assessment for fixed dose combination contains tolbutamide & voglibose for treating type II diabetes mellotus.
Material type: TextDescription: iv,99Dissertation note: 2023 SELVAKUMAR K.Item type | Current library | Home library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|---|
ACP-Thesis & Dissertations | Acharya & BM Reddy College of Pharmacy Dept. of Quality Assurance | Acharya & BM Reddy College of Pharmacy | ACP-Quality Assurance | 615.190 068 5 ANU (Browse shelf(Opens below)) | Available | ACP-T674 |
2023 SELVAKUMAR K.
There are no comments on this title.